The creation of the cancer drugs will be a huge breakthrough for mankind, but the disease is known, it is much better to prevent than to cure. And recently, as reported by Bloomberg, a team of scientists from the United States first tested on humans personified (that is, created for a specific patient) a vaccine against cancer.
The first person to receive a unique vaccine became Glenda cleaver, and funding was provided in the startup Moderna Therapeutics. Scientists sequenced the genome of the girls and found a number of mutations. These mutations, according to experts, in the future could cause the girl to the emergence of various forms of cancer. Based on the matrix RNA Glenda’s was created the vaccine with the correct “instructions” for the Assembly of molecules that target 20 proteins that are potentially hazardous. At this point the patient feels good, but scientists continue to monitor the Glenda.
It should be noted that this is not the first case of the creation of such a vaccine. In 2010, Dendreon was able to create a similar drug, but it was extremely expensive to manufacture and have not been able to prove its effectiveness. Not far behind the American researchers and their colleagues. For example, the German company BioNTech has completed the research phase of a vaccine against melanoma, and the Corporation plans Gritstone Oncology testing polyvaccine against cancer in 2018. In addition, scientists from Neon Therapeutics will receive the first test results with regards to their own vaccine for bladder cancer, lung cancer, melanoma and also next year. Given the huge interest a number of companies to develop a vaccine, I want to believe that such a medicine will be established in the near future and will save hundreds of lives.
In the USA man first made a vaccine against cancer
Vladimir Kuznetsov